COVID-19 Vaccines

ANCOR has announced a new campaign, As a DSP It's Up to Me!, designed to increase vaccine acceptance among direct support professionals (DSPs) so they can protect people with intellectual and developmental disabilities. A new COVID-19 Vaccine Toolkit has been designed to reduce vaccine hesitancy among DSPs and offer a range of resources to help community providers engage in conversations with DSPs that encourage them to get vaccinated.

Do you want updated, consumer-friendly handouts about the COVID-19 vaccine or booster recommendations, COVID-19 testing availability, or Medicare coverage during a public health emergency? The SHIP National Technical Assistance Center maintains fact sheets about these issues. The fact sheets have been updated to explain the following: 1) COVID-19 boosters are now recommended for people aged 12 and older, 2) How Original Medicare covers COVID-19 tests, but it does not cover at-home test, 3) Ways people with Original Medicare can access free at-home COVID-19 tests.

ACL has summarized the CDC's latest COVID-19 vaccination and booster reccomendations on their resources page. The webpage includes a section of resources for the Aging and Disability Networks and guidance for people who are immunocompromised.

On Monday, August 30th, CMS released two State Health Official (SHO) letters and a PowerPoint document that provide guidance regarding a variety of issues, including increases to state FMAP for several activities, opportunities to improve vaccine uptake among providers and beneficiaries, and habilitation services for children with disabilities.

ACL, the Office for Civil Rights (OCR), and the Office of the Assistant Secretary for Planning and Evaluation (ASPE) have published new resources to help states, vaccination providers, and others leading COVID-19 response activities improve access to vaccines for people with disabilities and older adults. These resources clarify legal requirements, explain barriers to vaccine access and provide examples of how the aging and disability network can help increase access.

On February 25. 2021, U.S. Senators Bob Casey (D-PA), Mark Kelly (D-AZ) and Kirsten Gillibrand (D-NY) introduced the Continued Funding for Senior Services During COVID-19 Act to ensure continued federal support for our Nation’s seniors. This legislation would allocate more than $1.5 billion to the aging network to continue providing essential services, such as meal delivery, vaccine outreach and programming and caregiver support.

On January 14, 2021 ADvancing States sent out a call for information about how states are rolling out the COVID-19 vaccine to people receiving home and community-based services and/or Older Americans Act services. Information about logistics plans, schedules, partnerships, and communications strategies were all welcomed. This resource reflects the information states sent in response to the call and will be periodically updated as we receive more information.

COVID-19 Antibody Testing of Patients with Chronic Conditions is being led by a team of researchers at Johns Hopkins Medicine. The purpose of the study is to determine the safety of the COVID-19 vaccine as well as COVID-19 antibody levels in patients who receive the vaccine with the following chronic conditions: HIV, an autoimmune condition, cirrhosis, or on home dialysis.

The National Guardianship Association, along with the American Bar Association Commission on Law and Aging and the National Center for State Courts have developed an FAQ for guardians about consent for the COVID-19 vaccine for residents of long-term care facilities.

CMS released an update to the COVID-19 Vaccines Toolkit that was released on 10/28/20 and first updated on 11/23/20. This update includes more information on vaccine administration reimbursement and outlines a streamlined review process available to states looking to quickly adjust vaccine administration reimbursement rates in state plans. The toolkit also provides more clarification on managed care network adequacy and the phased distribution and administration approved COVID-19 vaccines.